Seeking Alpha

Boston Scientific signs deal with The Medicines Company, shares rise

  • Boston Scientific (BSX +3.7%) trades notably higher in morning action.
  • The company has inked a co-promotion agreement with The Medicines Company (MDCO -1.4%) for the Promus PREMIER drug-eluting stent.
  • BSX is apparently looking to leverage MDCO's cardio sales force and product portfolio during the U.S. introduction of the new system. (PR)
  • In other company news, BSX says retrospective data presented at NANS shows the company's SCS system "provided highly significant pain relief three months after implantation." (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)